Reply to the following 2 Discussion posts

profileAni503
Replytothefollowing2DiscussionGERDandKawasakidiseaseposts.docx

Please Reply to the following 2 Discussion posts:

Requirement

APA format with intext citation

Word count minimum of 150 words per post, NOT including the references

References at least one high-level scholarly reference per post within the last 5 years in APA format.

Plagiarism free.

Turnitin receipt.

DISCUSSION POST # 1 Reply to Nozomi

Case study: 46-year-old male complains of chest pain described as pain in his midchest for the past couple of months that has progressively worsened over the last couple of weeks. He states it has worsened when he is going to bed at night or when he eats a large meal. He has been eating out a lot more over the past couple of months because he has been traveling a lot for work. He denies any nausea or vomiting. He has been taking OTC Tums for the past few weeks, but he has to take 10-12 a day and only gets minimal relief. He denies any unusual weight gain or loss. Physical exam reveals an obese, Caucasian male with mild epigastric tenderness. 

Based on this patient’s symptoms, the most likely diagnosis is gastroesophageal reflux disease (GERD), which often manifests with heartburn or burning sensation in the retrosternal area, especially after eating (Kahrilas, 2022). Other signs include regurgitation, dysphagia, chest pain, hoarseness, odynophagia, and nausea (Kahrilas, 2022). This patient is complaining of epigastric pain that has worsened over the last few weeks, and states that the pain is worse after meals and when going to bed. Some of the predisposing factors for GERD are obesity, eating large meals, emotional stress, and tight-fitting clothing (Cash et al., 2021). This patient admits to eating large meals, and he has been traveling frequently for work, which may be a stressor. Additionally, the physical examination showed that patient is obese. The patient has already tried TUMS with minimal relief. The gold standard treatment for GERD is proton-pump inhibitors (PPIs), such as omeprazole 40 mg orally once daily 30 to 60 minutes before meals (Kahrilas, 2022). Lifestyle modifications include weight loss, avoiding large meals, avoiding foods that lower the lower esophageal sphincter pressure, such as chocolate, caffeine, alcohol, and peppermint (Cash et al., 2021). The patient should be scheduled for a follow-up appointment in one to two weeks to evaluate the effectiveness of therapy (Cash et al., 2021). Although no routine endoscopy is indicated at this time, it may become necessary if the patient’s symptoms do not respond to PPI (Cash et al., 2021). 

DISCUSSION POST # 2 Reply to Minu

Case study:A 10-year-old Asian patient presents with an erythematous maculopapular rash, conjunctivitis, a mild fever of 102.1 and a strawberry tongue.

The emphasis of the evaluation would be HEENT because the patient is displaying symptoms more typical of that condition. For further information, I would also examine this patient from head to toe. To narrow down my differential diagnosis, I will gather the medical history, travel history, allergy history, and family history. Due to the patient's 102.1 F fever, I will do a CBC, UA with CS, ESR, and an echocardiography in order to get a more precise diagnosis.

Differential Diagnosis

1. Kawasaki Disease (M30.3): The patient is displaying typical Kawasaki disease (KD) symptoms including strawberry tongue, erythematous maculopapular rash, and conjunctivitis, in accordance with the criteria for the diagnosis of KD. KD is typically prevalent in Asian people.  But for appropriate laboratory and echocardiographic examination and treatment of these individuals, who run the risk of delayed diagnosis and have a greater prevalence of coronary artery aneurysms, early discovery and consideration of incomplete KD is crucial. Antibiotics are ineffective in treating Kawasaki illness. One of the main side effects of this illness is the development of coronary artery aneurysms in one-fourth of untreated individuals. "Intravenous immunoglobulin (IVIG) has been shown in clinical trials to reduce the risk of coronary artery aneurysms from 25% to 4%," is how I would treat the child (Morishita and Goldman, 2020